JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇱🇮
Cannabis — RestrictedEurope

Liechtenstein

Liechtenstein maintains strict cannabis prohibition under its Narcotics Act (Betäubungsmittelgesetz), which classifies cannabis as a controlled substance. The principality closely aligns its drug policy with neighboring Switzerland but has not adopted Switzerland's more liberal approach to personal use or CBD products.

Ask the Expert about Liechtenstein
Regulator
Amt für Gesundheit
Key Legislation
Betäubungsmittelgesetz
Year Legalized
N/A (cannabis remains prohibited)
Program Size
No medical or recreational cannabis p...

Key Facts

  • Cannabis possession, cultivation, and sale are illegal under the Betäubungsmittelgesetz (Narcotics Act)
  • Liechtenstein's drug policy is closely aligned with Swiss narcotics law through bilateral agreements
  • Small quantities for personal use may result in fines rather than imprisonment under prosecutorial discretion
  • CBD products with less than 1% THC are tolerated in line with Swiss market standards
  • The principality has no medical cannabis program and no legislative proposals to introduce one

Key Legislation

Betäubungsmittelgesetz (Narcotics Act, 2007 revision)

Regulatory Body

Amt für Gesundheit (Office of Public Health)

Country Info
ISO Code
LI
Region
Europe
Tier
Tier 3 — Restricted
Status
Cannabis — Restricted
Sources
Amt für Gesundheit (Office of Public Health)
Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.